FDA 483 - Catalent Ontario Limited - January 20, 2023

An FDA inspection of Catalent Ontario Limited, a non-sterile bulk drug manufacturer in Windsor, identified one observation. The firm was cited for not storing drug product reserve samples in an immediate container-closure system that matches the marketed product. This indicates a potential issue with sample integrity and regulatory compliance.